PMGC Holdings Inc. (ELAB) stock
ELABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/3095% below fair value
$1.48−0.18 (-10.84%)
Close on Nov 17, 2026Market cap $1.32MP/E –Yield –
PMGC total assets
Total assets on the balance sheet at the end of each period.
PMGC's total assets was $133.10M at Sep 30, 2026. For fiscal 2025 it was $12.87M, up 43.1% from the year before.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.87M | +43.1% |
| FY2024 | Dec 31, 2024 | $8.99M | +73.3% |
| FY2023 | Dec 31, 2023 | $5.19M | +174.3% |
| FY2022 | Dec 31, 2022 | $1.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $133.10M | +791.0% |
| Q2 FY2026 | Jun 30, 2026 | $36.56M | +290.0% |
| Q1 FY2026 | Mar 31, 2026 | $26.03M | +192.9% |
| Q4 FY2025 | Dec 31, 2025 | $12.87M | +43.1% |
| Q3 FY2025 | Sep 30, 2025 | $14.94M | +33.3% |
| Q2 FY2025 | Jun 30, 2025 | $9.38M | +84.5% |
| Q1 FY2025 | Mar 31, 2025 | $8.89M | +110.3% |
| Q4 FY2024 | Dec 31, 2024 | $8.99M | +73.3% |
| Q3 FY2024 | Sep 30, 2024 | $11.21M | -99.3% |
| Q2 FY2024 | Jun 30, 2024 | $5.08M | +168.5% |
| Q1 FY2024 | Mar 31, 2024 | $4.23M | – |
| Q4 FY2023 | Dec 31, 2023 | $5.19M | – |
| Q3 FY2023 | Sep 30, 2023 | $1.58B | – |
| Q4 FY2022 | Dec 31, 2022 | $1.89M | – |
See a number that looks wrong?